DMPA-SC stock: Cross-site trends by facility type-Reference-Cited by-同舟云学术

DMPA-SC stock: Cross-site trends by facility type

Published:2022 Issue: Volume:4 Page:100075
ISSN:2590-1516
Container-title:Contraception: X
language:en
Short-container-title:Contraception: X

Author:

Magalona Sophia^ORCID,Wood Shannon N.^ORCID,Makumbi Frederick,OlaOlorun Funmilola M.^ORCID,Omoluabi Elizabeth,Pierre Akilimali Z.,Guiella Georges,Cover Jane,Anglewicz Philip^ORCID

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference24 articles.

1. The coming-of-age of subcutaneous injectable contraception;Cole;Glob Health Sci Pract,2018

2. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal;Burke;Contraception,2014

3. Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda;Anglewicz;Contracept X,2019

4. Status Update: Global Progress with DMPA-SC and Self-injection Scale Up Quarterly Monitoring Report | Q4 2021,2022

5. Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda;Anglewicz;Contracept X,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey;Frontiers in Global Women's Health;2024-09-05

2. Self-injected contraceptives: does the investment reflect women’s preferences?;BMJ Global Health;2022-07